Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease

Movement Disorders

Volumn 13, Issue 2, 1998, Pages 336-338

  Syed, Nadir ^a   Murphy, John ^b   Zimmerman Jr , Thomas ^a   Mark, Margery H ^a   Sage, Jacob I ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b Associated Neurologists   (United States)

Author keywords

Dyskinesia; Fluctuations; Infusion; Levodopa; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG INFUSION; DYSKINESIA; FEMALE; FOLLOW UP; HUMAN; INFUSION PUMP; MALE; MOTOR DYSFUNCTION; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; INFUSION PUMPS; INFUSIONS, PARENTERAL; LEVODOPA; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 0031906233     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870130222     Document Type: Article

References (13)

1. Mouradian MM, Heuser IJE, Baronti R, Chase TN. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Ann Neurol 1990;27: 18-23.
2. Kurlan R, Rubin AJ, Miller C, Rivera-Calimlim L, Clarke A, Shoulson I. Duodenal delivery of levodopa for on-off fluctuations in parkinsonism: preliminary observations. Ann Neurol 1986;20: 262-265.
3. Sage JI, Schuh L, Heikkila RE, Duvoisin RC. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease. Clin Neuropharmacol 1988;11:36-44.
4. Sage JI, Trooskin S, Sonsalla PK, Heikkila RE. Experience with continuous enteral infusions in the treatment of 9 patients with advanced Parkinson's disease. Neurology 1989;39(suppl 2):60-63.
5. Cedarbaum JM, Silvestri RN, Kutt H. Sustained enteral administration of levodopa increases and interrupted infusion decreases levodopa dose requirements. Neurology 1990;40:995-997.
6. Kurth MC, Tetrud JW, Tanner CM, et al. Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations. Neurology 1993;43:1698-1703.
7. Sage JI, Mark MH. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations. Ann Neurol 1991;30:616-617.
8. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in parkinson's disease, vol II. Florham Park, NJ: Macmillan Healthcare Information, 1987;153-163, 293-304.
9. Sage JI, Trooskin S, Sonsalla PK, Heikkila RE, Duvoisin RC. Long-term duodenal infusions of levodopa for motor fluctuations in parkinsonism. Ann Neurol 1988;24:87-89.
10. Sage JI. Mark MH. The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease. Neurology 1992; 42(suppl 1):23-28.
11. Fabbrini G, Mouradian MM, Juncos JL, Schlegel J, Mohr E, Chase TN. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms. Part I. Ann Neurol 1988;24:366-371.
12. Mouradian MM, Juncos JL, Fabbrini G, Schlegel J, Bartko JJ, Chase TN. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II. Ann Neurol 1988;24:372-378.
13. Dogali M, Fazzini E, Kolodny E, et al. Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.